Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…
Sell
43
MRM Quote, Financials, Valuation and Earnings
Last price:
$1.25
Seasonality move
:
-22.37%
Day range:
$1.13 - $1.51
52-week range:
$0.34 - $8.39
Dividend yield:
0%
P/E ratio:
6.14x
P/S ratio:
0.14x
P/B ratio:
1.66x
Volume:
140.4K
Avg. volume:
577.7K
1-year change:
-76.94%
Market cap:
$9.9M
Revenue:
$54.9M
EPS (TTM):
-$0.12
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
-- | -- | -- | -- | $4.98 |
|
HMC
Honda Motor
|
$37.5B | -- | 2.54% | -- | $36.76 |
|
LGCB
Linkage Global
|
-- | -- | -- | -- | -- |
|
NPSKY
NSK
|
-- | -- | -- | -- | -- |
|
TKLF
Tokyo Lifestyle
|
-- | -- | -- | -- | -- |
|
TM
Toyota Motor
|
$83.6B | -- | 7.35% | -- | $225.82 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
$1.25 | $4.98 | $9.9M | 6.14x | $0.00 | 0% | 0.14x |
|
HMC
Honda Motor
|
$29.58 | $36.76 | $41.7B | 8.46x | $0.67 | 4.8% | 0.32x |
|
LGCB
Linkage Global
|
$2.24 | -- | $6.9M | -- | $0.00 | 0% | 0.46x |
|
NPSKY
NSK
|
$8.98 | -- | $2.2B | 31.38x | $0.23 | 4.67% | 0.42x |
|
TKLF
Tokyo Lifestyle
|
$3.89 | -- | $16.4M | 1.82x | $0.00 | 0% | 0.07x |
|
TM
Toyota Motor
|
$182.88 | $225.82 | $238.3B | 7.78x | $2.60 | 2.99% | 0.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
129.27% | 3.661 | 51.51% | 0.23x |
|
HMC
Honda Motor
|
-- | -0.931 | -- | 1.00x |
|
LGCB
Linkage Global
|
18.89% | -3.128 | 2.68% | 0.70x |
|
NPSKY
NSK
|
-- | -0.495 | -- | 1.44x |
|
TKLF
Tokyo Lifestyle
|
62.9% | 0.279 | 269.64% | 1.08x |
|
TM
Toyota Motor
|
51.92% | -0.679 | 109.51% | 1.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
-- | -- | -6.44% | -- | -- | -- |
|
HMC
Honda Motor
|
$7.5B | $482.4M | 5.97% | 6.34% | 2.03% | -$990.6M |
|
LGCB
Linkage Global
|
-- | -- | -29.38% | -42.09% | -- | -- |
|
NPSKY
NSK
|
$271.2M | $25.2M | 1.54% | 1.55% | 3.42% | -$21.3M |
|
TKLF
Tokyo Lifestyle
|
-- | -- | 6.96% | 19.93% | -- | -- |
|
TM
Toyota Motor
|
$15.3B | $7.3B | 6.39% | 13.1% | 8.2% | $605.5M |
MEDIROM Healthcare Technologies vs. Competitors
-
Which has Higher Returns MRM or HMC?
Honda Motor has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.57%. MEDIROM Healthcare Technologies's return on equity of -- beat Honda Motor's return on equity of 6.34%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M HMCHonda Motor21.23% $0.18 $84.4B -
What do Analysts Say About MRM or HMC?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 298.75%. On the other hand Honda Motor has an analysts' consensus of $36.76 which suggests that it could grow by 24.26%. Given that MEDIROM Healthcare Technologies has higher upside potential than Honda Motor, analysts believe MEDIROM Healthcare Technologies is more attractive than Honda Motor.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 HMCHonda Motor2 0 0 -
Is MRM or HMC More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Honda Motor has a beta of 0.548, suggesting its less volatile than the S&P 500 by 45.247%.
-
Which is a Better Dividend Stock MRM or HMC?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Honda Motor offers a yield of 4.8% to investors and pays a quarterly dividend of $0.67 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Honda Motor pays out 41.61% of its earnings as a dividend. Honda Motor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MRM or HMC?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Honda Motor quarterly revenues of $35.2B. MEDIROM Healthcare Technologies's net income of -- is lower than Honda Motor's net income of $200.5M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 6.14x while Honda Motor's PE ratio is 8.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.14x versus 0.32x for Honda Motor. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.14x 6.14x -- -- HMCHonda Motor0.32x 8.46x $35.2B $200.5M
-
Which has Higher Returns MRM or LGCB?
Linkage Global has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Linkage Global's return on equity of -42.09%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M LGCBLinkage Global-- -- $8.3M -
What do Analysts Say About MRM or LGCB?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 298.75%. On the other hand Linkage Global has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Linkage Global, analysts believe MEDIROM Healthcare Technologies is more attractive than Linkage Global.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 LGCBLinkage Global0 0 0 -
Is MRM or LGCB More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Linkage Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MRM or LGCB?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Linkage Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Linkage Global pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or LGCB?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Linkage Global quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Linkage Global's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 6.14x while Linkage Global's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.14x versus 0.46x for Linkage Global. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.14x 6.14x -- -- LGCBLinkage Global0.46x -- -- --
-
Which has Higher Returns MRM or NPSKY?
NSK has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.99%. MEDIROM Healthcare Technologies's return on equity of -- beat NSK's return on equity of 1.55%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M NPSKYNSK20.76% $0.05 $4.5B -
What do Analysts Say About MRM or NPSKY?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 298.75%. On the other hand NSK has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than NSK, analysts believe MEDIROM Healthcare Technologies is more attractive than NSK.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 NPSKYNSK0 0 0 -
Is MRM or NPSKY More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NSK has a beta of 0.410, suggesting its less volatile than the S&P 500 by 58.959%.
-
Which is a Better Dividend Stock MRM or NPSKY?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NSK offers a yield of 4.67% to investors and pays a quarterly dividend of $0.23 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. NSK pays out 146.95% of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or NPSKY?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than NSK quarterly revenues of $1.3B. MEDIROM Healthcare Technologies's net income of -- is lower than NSK's net income of $12.9M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 6.14x while NSK's PE ratio is 31.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.14x versus 0.42x for NSK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.14x 6.14x -- -- NPSKYNSK0.42x 31.38x $1.3B $12.9M
-
Which has Higher Returns MRM or TKLF?
Tokyo Lifestyle has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Tokyo Lifestyle's return on equity of 19.93%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M TKLFTokyo Lifestyle-- -- $105.8M -
What do Analysts Say About MRM or TKLF?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 298.75%. On the other hand Tokyo Lifestyle has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Tokyo Lifestyle, analysts believe MEDIROM Healthcare Technologies is more attractive than Tokyo Lifestyle.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 TKLFTokyo Lifestyle0 0 0 -
Is MRM or TKLF More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tokyo Lifestyle has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MRM or TKLF?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tokyo Lifestyle offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Tokyo Lifestyle pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or TKLF?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Tokyo Lifestyle quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Tokyo Lifestyle's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 6.14x while Tokyo Lifestyle's PE ratio is 1.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.14x versus 0.07x for Tokyo Lifestyle. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.14x 6.14x -- -- TKLFTokyo Lifestyle0.07x 1.82x -- --
-
Which has Higher Returns MRM or TM?
Toyota Motor has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 5.38%. MEDIROM Healthcare Technologies's return on equity of -- beat Toyota Motor's return on equity of 13.1%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M TMToyota Motor18.86% $3.38 $505.7B -
What do Analysts Say About MRM or TM?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 298.75%. On the other hand Toyota Motor has an analysts' consensus of $225.82 which suggests that it could grow by 23.48%. Given that MEDIROM Healthcare Technologies has higher upside potential than Toyota Motor, analysts believe MEDIROM Healthcare Technologies is more attractive than Toyota Motor.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 TMToyota Motor2 1 0 -
Is MRM or TM More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Toyota Motor has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.206%.
-
Which is a Better Dividend Stock MRM or TM?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Toyota Motor offers a yield of 2.99% to investors and pays a quarterly dividend of $2.60 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Toyota Motor pays out 23.76% of its earnings as a dividend. Toyota Motor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MRM or TM?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Toyota Motor quarterly revenues of $81.1B. MEDIROM Healthcare Technologies's net income of -- is lower than Toyota Motor's net income of $4.4B. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 6.14x while Toyota Motor's PE ratio is 7.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.14x versus 0.77x for Toyota Motor. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.14x 6.14x -- -- TMToyota Motor0.77x 7.78x $81.1B $4.4B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
80
SBET alert for May 29
SharpLink Gaming [SBET] is up 48.29% over the past day.
Buy
100
BOX alert for May 29
Box [BOX] is down 0.57% over the past day.
Sell
22
OKTA alert for May 29
Okta [OKTA] is up 1.32% over the past day.
